1609393-89-6 Usage
General Description
4,6-dichloro-N-trideuteromethylpyridazine-3-carboxamide is a chemical compound featuring two chlorine atoms and a trideuteromethyl group attached to a pyridazine ring structure. The compound also includes a carboxamide functional group. It is commonly used in organic synthesis and pharmaceutical research due to its potential for medicinal and biological applications. As a derivative of pyridazine, it may exhibit properties that are beneficial for drug development, such as enhancing bioavailability or binding affinity to specific biological targets. Additionally, the deuterium substitution in the methyl group can offer advantages in terms of pharmacokinetics and metabolic stability. Overall, 4,6-dichloro-N-trideuteromethylpyridazine-3-carboxamide is a valuable compound for various scientific and industrial purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 1609393-89-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,0,9,3,9 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1609393-89:
(9*1)+(8*6)+(7*0)+(6*9)+(5*3)+(4*9)+(3*3)+(2*8)+(1*9)=196
196 % 10 = 6
So 1609393-89-6 is a valid CAS Registry Number.
1609393-89-6Relevant articles and documents
TYK2 Inhibitor compounds containing alkoxy and amide groups
-
Paragraph 0101-0104, (2021/11/21)
The invention belongs to the field of pharmaceutical chemistry, and provides TYK2 inhibitor compounds containing alkoxy and amide groups and a preparation method thereof, and relates to application of the compound in preparation of medicines for treating
SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS
-
Paragraph 0432-0434; 0426, (2019/06/07)
Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
